v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 47,590 $ 61,929
Adjustments to reconcile net income to net cash flows from operating activities:    
Provision for credit losses on accounts receivable 3,346 1,552
Reserve for product returns 987 1,111
Provision for credit losses on notes receivable 3 749
Amortization and depreciation 18,056 14,558
Amortization of debt issuance costs 1,586 3,002
Amortization of operating leases 7,587 7,829
Deferred income taxes 6,205 (15,673)
Stock-based compensation 15,625 18,392
Distributions on investments in unconsolidated entities 6,430 0
Loss from investments in unconsolidated entities 4,422 3,454
Other adjustments 710 67
Changes in operating assets and liabilities (net of business acquisitions):    
Accounts receivable (24,204) 1,574
Inventory (24) (1,544)
Other current and non-current assets 5,471 (4,732)
Accounts payable and other current liabilities 5,193 (39,711)
Deferred revenue 1,930 682
Operating lease liabilities (8,320) (6,393)
Other liabilities (71) (73)
Cash flows from operating activities 92,522 46,773
Cash flows used in investing activities:    
Business acquisitions, net of cash acquired 0 (23,412)
Additions to property and equipment (5,759) (10,667)
Issuances of notes receivable (4,342) (23,500)
Receipt of payments on notes receivable 61 49
Capitalized software development costs (538) (758)
Proceeds from sale of investments in unconsolidated entities 6,039 0
Purchase of investments in unconsolidated entities (16,173) (174,700)
Cash flows used in investing activities (20,712) (232,988)
Cash flows used in financing activities:    
Repayments of convertible senior notes (500,000) 0
Payments of deferred consideration for acquisitions and investments in unconsolidated entities (12,089) (1,741)
Purchases of treasury stock, including transaction costs (45,020) (10,167)
Issuances of common stock from equity-based plans 2,102 2,314
Cash flows used in financing activities (555,007) (9,594)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (73) (184)
Net decrease in cash, cash equivalents and restricted cash (483,270) (195,993)
Cash, cash equivalents and restricted cash at beginning of the period 968,807 1,229,132
Cash, cash equivalents and restricted cash at end of the period 485,537 1,033,139
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 479,418 1,024,862
Restricted cash included in other current assets, net, and other assets, net 6,119 8,277
Total cash, cash equivalents and restricted cash $ 485,537 $ 1,033,139